Insulet | PODD - DŁUG





DŁUG Zmiana Data
Abbott USD 13.86B 919M 2025-12
Align Technology USD 114.45M 6.82M 2025-12
AtriCure USD 73.38M 3.35M 2025-12
Avanos Medical USD 129.1M 4.6M 2025-12
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cardinal Health USD 8.92B 111M 2026-03
Cooper Companies USD 2.5B 5.6M 2025-12
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Eli Lilly USD 42.5B 3.6M 2025-12
Globus Medical USD 118.66M 687K 2025-12
ICU Medical USD 1.28B 79.88M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teleflex USD 2.73B 43.5M 2025-12
West Pharmaceutical Services USD 202.8M 0 2026-03
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03